Seratrodast
CAS No. 112665-43-7
Seratrodast( AA2414 | A-73001 | ABT-001 )
Catalog No. M10444 CAS No. 112665-43-7
Seratrodast (INN) is a thromboxane A2 (TXA2) receptor (TP receptor) antagonist used primarily in the treatment of asthma.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 35 | In Stock |
|
| 10MG | 32 | In Stock |
|
| 25MG | 58 | In Stock |
|
| 50MG | 79 | In Stock |
|
| 100MG | 114 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 276 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSeratrodast
-
NoteResearch use only, not for human use.
-
Brief DescriptionSeratrodast (INN) is a thromboxane A2 (TXA2) receptor (TP receptor) antagonist used primarily in the treatment of asthma.
-
DescriptionSeratrodast (INN) is a thromboxane A2 (TXA2) receptor (TP receptor) antagonist used primarily in the treatment of asthma. It was the first TP receptor antagonist that was developed as an anti-asthmatic drug and received marketing approval in Japan in 1997.
-
In Vitro——
-
In Vivo——
-
SynonymsAA2414 | A-73001 | ABT-001
-
PathwayChromatin/Epigenetic
-
TargetCOX
-
RecptorCOX| TXA2R
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number112665-43-7
-
Formula Weight354.44
-
Molecular FormulaC22H26O4
-
Purity>98% (HPLC)
-
SolubilitySoluble in Water
-
SMILESO=C(O)CCCCCC(C(C1=O)=C(C)C(C(C)=C1C)=O)C2=CC=CC=C2
-
Chemical Name(+-)-7-(3,5,6-Trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Endo S, Akiyama K. Nihon Rinsho. 1996 Nov;54(11):3045-8.
molnova catalog
related products
-
COX-2-IN-6
COX-2-IN-6 is a potent, selective, and orally available cyclooxygenase-2 (COX-2) inhibitor with an IC50 of 0.84 μM and a Ki of 69 nM.COX-2-IN-6 inhibits COX-2-driven PGE2 synthesis with an IC50 of 0.60 μM.COX-2-IN-6 is used to prevent colorectal cancer.
-
LM-1685
LM-1685 is a potent and selective inhibitor of COX-2 IN human monocytes and whole blood with IC50 of 0.65μM and IC50 = 4.3μM, respectively, and is a potential compound for the treatment of inflammation.
-
Hydroxytoluic acid
The salts or esters of salicylic acids, or salicylate esters of an organic acid.
Cart
sales@molnova.com